{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:35:13Z","timestamp":1793039713805,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["NSFC 81260215"],"award-info":[{"award-number":["NSFC 81260215"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004607","name":"Natural Science Foundation of Guangxi Province","doi-asserted-by":"publisher","award":["2012GXNSFAA053142"],"award-info":[{"award-number":["2012GXNSFAA053142"]}],"id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.lfs.2019.117091","type":"journal-article","created":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T02:30:50Z","timestamp":1574303450000},"page":"117091","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["The role of iron in Parkinson's disease monkeys assessed by susceptibility weighted imaging and inductively coupled plasma mass spectrometry"],"prefix":"10.1016","volume":"240","author":[{"given":"Shao-Jun","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-De","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan-Shan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Rong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2019.117091_bb0005","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.arr.2014.01.004","article-title":"Ageing and Parkinson\u2019s disease: why is advancing age the biggest risk factor?","volume":"14","author":"Reeve","year":"2014","journal-title":"Ageing Res. Rev."},{"issue":"5","key":"10.1016\/j.lfs.2019.117091_bb0010","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1212\/01.wnl.0000247740.47667.03","article-title":"Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030","volume":"68","author":"Dorsey","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.lfs.2019.117091_bb0015","doi-asserted-by":"crossref","first-page":"134313","DOI":"10.1016\/j.neulet.2019.134313","article-title":"Meta-analysis of related factors of impulse control disorders in patients with Parkinson's disease","volume":"707","author":"Liu","year":"2019","journal-title":"Neurosci Lett"},{"issue":"2","key":"10.1016\/j.lfs.2019.117091_bb0020","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/mds.26370","article-title":"Alpha-synuclein propagation: new insights from animal models","volume":"31","author":"Dehay","year":"2016","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.lfs.2019.117091_bb0025","article-title":"Effects of non-pharmacological treatments on quality of life in Parkinson\u2019s disease: a review","volume":"4","author":"Ahn","year":"2017","journal-title":"J. Parkinsons Dis. Alzheimers Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.lfs.2019.117091_bb0030","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/jnc.13691","article-title":"The clinical symptoms of Parkinson\u2019s disease","volume":"139","author":"Sveinbjornsdottir","year":"2016","journal-title":"J. Neurochem."},{"issue":"7","key":"10.1016\/j.lfs.2019.117091_bb0035","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00702-019-02033-9","article-title":"Disease stage dependency of motor and non-motor fluctuations in Parkinson\u2019s disease","volume":"126","author":"Storch","year":"2019","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.lfs.2019.117091_bb0040","article-title":"Melatonin and Parkinson Disease: current status and future perspectives for molecular mechanisms","author":"Tamtaji","year":"2019","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.lfs.2019.117091_bb0045","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fnins.2019.00114","article-title":"Nitric oxide, iron and neurodegeneration","volume":"13","author":"Liu","year":"2019","journal-title":"Front. Neurosci."},{"issue":"6","key":"10.1016\/j.lfs.2019.117091_bb0050","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","article-title":"Mechanisms underlying inflammation in neurodegeneration","volume":"140","author":"Glass","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2019.117091_bb0055","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.intimp.2018.12.019","article-title":"The mechanisms of NLRP3 inflammasome\/pyroptosis activation and their role in Parkinson\u2019s disease","volume":"67","author":"Wang","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"Suppl. 1","key":"10.1016\/j.lfs.2019.117091_bb0060","first-page":"34","article-title":"Iron in brain function and dysfunction with emphasis on Parkinson\u2019s disease","volume":"31","author":"Youdim","year":"1991","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.lfs.2019.117091_bb0065","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1750-1326-9-27","article-title":"Iron accumulation confers neurotoxicity to a vulnerable population of nigral neurons: implications for Parkinson\u2019s disease","volume":"9","author":"Ayton","year":"2014","journal-title":"Mol. Neurodegener."},{"issue":"8569","key":"10.1016\/j.lfs.2019.117091_bb0070","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0140-6736(87)91361-4","article-title":"Increased nigral iron content in postmortem parkinsonian brain","volume":"2","author":"Dexter","year":"1987","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.lfs.2019.117091_bb0075","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF01244786","article-title":"Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain","volume":"74","author":"Sofic","year":"1988","journal-title":"J. Neural Transm."},{"issue":"16 Pt 2","key":"10.1016\/j.lfs.2019.117091_bb0080","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1212\/01.wnl.0000286384.31050.b5","article-title":"Midbrain iron content in early Parkinson disease: a potential biomarker of disease status","volume":"70","author":"Martin","year":"2008","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.lfs.2019.117091_bb0085","doi-asserted-by":"crossref","first-page":"e57904","DOI":"10.1371\/journal.pone.0057904","article-title":"Is R2* a new MRI biomarker for the progression of Parkinson's disease? A longitudinal follow-up","volume":"8","author":"Ulla","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2019.117091_bb0090","first-page":"378278","article-title":"Dysregulation of iron metabolism in Alzheimer\u2019s disease, Parkinson\u2019s disease, and amyotrophic lateral sclerosis","volume":"2011","author":"Oshiro","year":"2011","journal-title":"Adv. Pharmacol. Sci."},{"key":"10.1016\/j.lfs.2019.117091_bb0095","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.freeradbiomed.2013.01.017","article-title":"Targeting dysregulation of brain iron homeostasis in Parkinson\u2019s disease by iron chelators","volume":"62","author":"Weinreb","year":"2013","journal-title":"Free Radic. Biol. Med."},{"issue":"4","key":"10.1016\/j.lfs.2019.117091_bb0100","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1212\/WNL.0000000000003533","article-title":"Dose-dependent progression of parkinsonism in manganese-exposed welders","volume":"88","author":"Racette","year":"2017","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.lfs.2019.117091_bb0105","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1007\/s12640-019-00048-4","article-title":"Attenuation of endoplasmic reticulum stress, impaired calcium homeostasis, and altered bioenergetic functions in MPP(+)-exposed SH-SY5Y cells pretreated with rutin","volume":"36","author":"Enogieru","year":"2019","journal-title":"Neurotox. Res."},{"issue":"1","key":"10.1016\/j.lfs.2019.117091_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF03033302","article-title":"Disturbance of iron metabolism in Parkinson\u2019s disease \u2013 ultrasonography as a biomarker","volume":"9","author":"Berg","year":"2006","journal-title":"Neurotox. Res."},{"issue":"3","key":"10.1016\/j.lfs.2019.117091_bb0115","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/mrm.1910320309","article-title":"Assessment of relative brain iron concentrations using T2-weighted and T2*-weighted MRI at 3 tesla","volume":"32","author":"Ordidge","year":"1994","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.lfs.2019.117091_bb0120","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.brainres.2010.03.036","article-title":"Characterizing iron deposition in Parkinson\u2019s disease using susceptibility-weighted imaging: an in vivo MR study","volume":"1330","author":"Zhang","year":"2010","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.lfs.2019.117091_bb0125","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/mds.870060205","article-title":"Oral levodopa dose-response study in MPTP-induced hemiparkinsonian monkeys: assessment with a new rating scale for monkey parkinsonism","volume":"6","author":"Kurlan","year":"2010","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.lfs.2019.117091_bb0130","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jep.2013.04.038","article-title":"Cyperi Rhizoma inhibits the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced reduction in nigrostriatal dopaminergenic neurons in estrogen-deprived mice","volume":"148","author":"Kim","year":"2013","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.lfs.2019.117091_bb0135","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.talanta.2016.09.070","article-title":"Single-particle inductively coupled plasma mass spectroscopy analysis of size and number concentration in mixtures of monometallic and bimetallic (core-shell) nanoparticles","volume":"162","author":"Merrifield","year":"2017","journal-title":"Talanta"},{"issue":"Pt 10","key":"10.1016\/j.lfs.2019.117091_bb0140","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1242\/jcs.03443","article-title":"A cell biological perspective on mitochondrial dysfunction in Parkinson disease and other neurodegenerative diseases","volume":"120","author":"Mandemakers","year":"2007","journal-title":"J. Cell Sci."},{"issue":"6","key":"10.1016\/j.lfs.2019.117091_bb0145","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.lfs.2019.117091_bb0150","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF02741387","article-title":"Tyrosine hydroxylase and Parkinson\u2019s disease","volume":"16","author":"Haavik","year":"1998","journal-title":"Mol. Neurobiol."},{"issue":"Suppl. 4","key":"10.1016\/j.lfs.2019.117091_bb0155","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/S1353-8020(09)70829-6","article-title":"From the MPTP-treated primate to the treatment of motor complications in Parkinson\u2019s disease","volume":"15","author":"Jenner","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"issue":"Suppl. 2","key":"10.1016\/j.lfs.2019.117091_bb0160","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1016\/j.parkreldis.2008.04.012","article-title":"Modeling PD pathogenesis in mice: advantages of a chronic MPTP protocol","volume":"14","author":"Meredith","year":"2008","journal-title":"Parkinsonism Relat. Disord."},{"issue":"Suppl. 3","key":"10.1016\/j.lfs.2019.117091_bb0165","first-page":"29","article-title":"Physiology of MPTP tremor","volume":"13","author":"Bergman","year":"1998","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.lfs.2019.117091_bb0170","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0306-4522(99)00437-6","article-title":"Striatal dopaminergic correlates of stable parkinsonism and degree of recovery in old-world primates one year after MPTP treatment","volume":"95","author":"Elsworth","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.lfs.2019.117091_bb0175","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.bbi.2017.04.016","article-title":"GPER activation is effective in protecting against inflammation-induced nigral dopaminergic loss and motor function impairment","volume":"64","author":"Mendes-Oliveira","year":"2017","journal-title":"Brain Behav. Immun."},{"issue":"4","key":"10.1016\/j.lfs.2019.117091_bb0180","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrn.2017.25","article-title":"The two-century journey of Parkinson disease research","volume":"18","author":"Przedborski","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.lfs.2019.117091_bb0185","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1001\/jamaneurol.2016.4467","article-title":"Assessment of safety and efficacy of safinamide as a levodopa adjunct in patients with Parkinson disease and motor fluctuations: a randomized clinical trial","volume":"74","author":"Schapira","year":"2017","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.lfs.2019.117091_bb0190","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.parkreldis.2019.02.030","article-title":"Speculating the timing of iron deposition in the putamen in multiple system atrophy","volume":"63","author":"Lee","year":"2019","journal-title":"Parkinsonism Relat. Disord."},{"issue":"7","key":"10.1016\/j.lfs.2019.117091_bb0195","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1021\/acs.accounts.9b00248","article-title":"Metal ions in Alzheimer\u2019s disease: a key role or not?","volume":"52","author":"Liu","year":"2019","journal-title":"Acc. Chem. Res."},{"issue":"4","key":"10.1016\/j.lfs.2019.117091_bb0200","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/mds.27307","article-title":"MRI supervised and unsupervised classification of Parkinson\u2019s disease and multiple system atrophy","volume":"33","author":"Peran","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.lfs.2019.117091_bb0205","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.freeradbiomed.2018.04.002","article-title":"Brain mitochondrial iron accumulates in Huntington\u2019s disease, mediates mitochondrial dysfunction, and can be removed pharmacologically","volume":"120","author":"Agrawal","year":"2018","journal-title":"Free Radic. Biol. Med."},{"issue":"3","key":"10.1016\/j.lfs.2019.117091_bb0210","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/(SICI)1098-2345(1998)45:3<291::AID-AJP5>3.0.CO;2-R","article-title":"Topographical localization of iron in brains of the aged fat-tailed dwarf lemur (Cheirogaleus medius) and gray lesser mouse lemur (Microcebus murinus)","volume":"45","author":"Gilissen","year":"1998","journal-title":"Am. J. Primatol."},{"key":"10.1016\/j.lfs.2019.117091_bb0215","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1196\/annals.1297.063","article-title":"Iron accumulation during cellular senescence","volume":"1019","author":"Killilea","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"2","key":"10.1016\/j.lfs.2019.117091_bb0220","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/ene.13208","article-title":"Motor associations of iron accumulation in deep grey matter nuclei in Parkinson\u2019s disease: a cross-sectional study of iron-related magnetic resonance imaging susceptibility","volume":"24","author":"Martin-Bastida","year":"2017","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.lfs.2019.117091_bb0225","doi-asserted-by":"crossref","first-page":"36669","DOI":"10.1038\/srep36669","article-title":"Meta-analysis of brain iron levels of Parkinson\u2019s disease patients determined by postmortem and MRI measurements","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.lfs.2019.117091_bb0230","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.3109\/10715762.2015.1032958","article-title":"Neuroprotective effects of ginkgetin against neuroinjury in Parkinson\u2019s disease model induced by MPTP via chelating iron","volume":"49","author":"Wang","year":"2015","journal-title":"Free Radic. Res."},{"issue":"12","key":"10.1016\/j.lfs.2019.117091_bb0235","doi-asserted-by":"crossref","first-page":"e0144848","DOI":"10.1371\/journal.pone.0144848","article-title":"Iron chelators and antioxidants regenerate neuritic tree and nigrostriatal fibers of MPP+\/MPTP-lesioned dopaminergic neurons","volume":"10","author":"Aguirre","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.lfs.2019.117091_bb0240","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s40478-017-0456-2","article-title":"The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson's disease","volume":"5","author":"Finkelstein","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"issue":"1","key":"10.1016\/j.lfs.2019.117091_bb0245","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/jnr.490350109","article-title":"Infusion of iron into the rat substantia nigra: nigral pathology and dose-dependent loss of striatal dopaminergic markers","volume":"35","author":"Sengstock","year":"1993","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.lfs.2019.117091_bb0250","doi-asserted-by":"crossref","first-page":"110717","DOI":"10.1016\/j.jinorgbio.2019.110717","article-title":"Iron and other metals in the pathogenesis of Parkinson's disease: toxic effects and possible detoxification","volume":"199","author":"Bjorklund","year":"2019","journal-title":"J Inorg Biochem"},{"issue":"18","key":"10.1016\/j.lfs.2019.117091_bb0255","first-page":"2605","article-title":"Assessment of cerebral iron content in patients with Parkinson\u2019s disease by the susceptibility-weighted MRI","volume":"18","author":"Wu","year":"2014","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.lfs.2019.117091_bb0260","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3174\/ajnr.A2765","article-title":"Different iron-deposition patterns of multiple system atrophy with predominant parkinsonism and idiopathetic Parkinson diseases demonstrated by phase-corrected susceptibility-weighted imaging","volume":"33","author":"Wang","year":"2012","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"2","key":"10.1016\/j.lfs.2019.117091_bb0265","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/jmri.1880070203","article-title":"Theory and application of static field inhomogeneity effects in gradient-echo imaging","volume":"7","author":"Reichenbach","year":"1997","journal-title":"J. Magn. Reson. Imaging"},{"issue":"1","key":"10.1016\/j.lfs.2019.117091_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mri.2004.10.001","article-title":"Imaging iron stores in the brain using magnetic resonance imaging","volume":"23","author":"Haacke","year":"2005","journal-title":"Magn. Reson. Imaging"},{"issue":"3","key":"10.1016\/j.lfs.2019.117091_bb0275","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/mrm.20198","article-title":"Susceptibility weighted imaging (SWI)","volume":"52","author":"Haacke","year":"2004","journal-title":"Magn. Reson. Med."},{"issue":"4","key":"10.1016\/j.lfs.2019.117091_bb0280","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1212\/WNL.0000000000003543","article-title":"Understanding of the role of manganese in parkinsonism and Parkinson disease","volume":"88","author":"Ratner","year":"2017","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.lfs.2019.117091_bb0285","first-page":"571","article-title":"Increased DMT1 expression and iron content in MPTP-treated C57BL\/6 mice","volume":"55","author":"Jiang","year":"2003","journal-title":"Sheng Li Xue Bao"},{"issue":"2","key":"10.1016\/j.lfs.2019.117091_bb0290","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.neurobiolaging.2014.10.021","article-title":"Ndfip1 attenuated 6-OHDA-induced iron accumulation via regulating the degradation of DMT1","volume":"36","author":"Jia","year":"2015","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.lfs.2019.117091_bb0295","doi-asserted-by":"crossref","first-page":"21113","DOI":"10.1038\/srep21113","article-title":"Iron mitigates DMT1-mediated manganese cytotoxicity via the ASK1-JNK signaling axis: implications of iron supplementation for manganese toxicity","volume":"6","author":"Tai","year":"2016","journal-title":"Sci. Rep."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320519310185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320519310185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:43:03Z","timestamp":1793036583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320519310185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":59,"alternative-id":["S0024320519310185"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2019.117091","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of iron in Parkinson's disease monkeys assessed by susceptibility weighted imaging and inductively coupled plasma mass spectrometry","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2019.117091","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117091"}}